Oncosil Medical Ltd
ASX:OSL
Oncosil Medical Ltd
ASX:OSL
Price:
0.505
AUD
2.54%
Market Closed
Market Cap:
AU$11.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Oncosil Medical Ltd
ASX:OSL
|
AU |
|
M
|
Moorim P&P Co Ltd
KRX:009580
|
KR |
|
Avidity Biosciences Inc
NASDAQ:RNA
|
US |
|
J
|
Just Energy Group Inc
XTSX:JE
|
CA |
|
N
|
Nanotech Indonesia Global Tbk PT
IDX:NANO
|
ID |
|
M
|
Multi-Chem Ltd
SGX:AWZ
|
SG |
|
Clearview Wealth Ltd
ASX:CVW
|
AU |
|
I
|
Industrias Penoles SAB de CV
BMV:PE&OLES
|
MX |
Balance Sheet
Balance Sheet Decomposition
Oncosil Medical Ltd
Oncosil Medical Ltd
Balance Sheet Decomposition is not available for
Oncosil Medical Ltd
Oncosil Medical Ltd
Balance Sheet
Oncosil Medical Ltd
Oncosil Medical Ltd
Currency: AUD
| Jun-2005 | Jun-2006 | Jun-2007 | Jun-2008 | Jun-2009 | Jun-2010 | Jun-2011 | Jun-2012 | Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||
| Cash & Cash Equivalents |
1
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
2
|
10
|
8
|
15
|
8
|
21
|
12
|
11
|
9
|
5
|
5
|
|
| Cash |
1
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
2
|
0
|
0
|
0
|
0
|
21
|
12
|
11
|
9
|
5
|
5
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
8
|
15
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
2
|
2
|
2
|
1
|
1
|
2
|
2
|
3
|
7
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
4
|
4
|
3
|
1
|
1
|
1
|
1
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Total Current Assets |
1
|
3
|
3
|
2
|
2
|
2
|
3
|
3
|
4
|
10
|
1
|
16
|
12
|
20
|
12
|
24
|
14
|
13
|
11
|
6
|
7
|
|
| PP&E Net |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
2
|
2
|
2
|
1
|
0
|
0
|
0
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
2
|
2
|
2
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
2
|
2
|
2
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
8
+762%
|
7
-15%
|
6
-12%
|
5
-15%
|
3
-43%
|
3
+2%
|
3
-17%
|
6
+148%
|
12
+97%
|
0
N/A
|
16
N/A
|
12
-26%
|
20
+68%
|
12
-41%
|
24
+106%
|
14
-41%
|
13
-8%
|
11
-12%
|
7
-41%
|
7
+6%
|
|
| Liabilities | ||||||||||||||||||||||
| Accounts Payable |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Total Current Liabilities |
0
|
1
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
1
|
2
|
2
|
2
|
2
|
2
|
4
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
3
+5 360%
|
2
-15%
|
2
-10%
|
1
-54%
|
0
-60%
|
0
-68%
|
0
-67%
|
0
+375%
|
0
-37%
|
0
N/A
|
1
N/A
|
2
+54%
|
2
+3%
|
1
-43%
|
2
+117%
|
2
+14%
|
2
-22%
|
2
-16%
|
2
+24%
|
4
+104%
|
|
| Equity | ||||||||||||||||||||||
| Common Stock |
1
|
6
|
6
|
9
|
9
|
9
|
10
|
10
|
14
|
24
|
0
|
36
|
37
|
52
|
52
|
70
|
70
|
80
|
87
|
90
|
96
|
|
| Retained Earnings |
0
|
0
|
2
|
4
|
4
|
6
|
7
|
7
|
8
|
12
|
0
|
21
|
27
|
34
|
42
|
48
|
59
|
69
|
77
|
85
|
93
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
5
+507%
|
5
-14%
|
4
-13%
|
4
+5%
|
3
-40%
|
3
+13%
|
2
-15%
|
6
+144%
|
12
+101%
|
0
N/A
|
15
N/A
|
10
-32%
|
18
+79%
|
11
-41%
|
22
+105%
|
12
-47%
|
11
-5%
|
10
-11%
|
5
-52%
|
3
-34%
|
|
| Total Liabilities & Equity |
1
N/A
|
8
+762%
|
7
-15%
|
6
-12%
|
5
-15%
|
3
-43%
|
3
+2%
|
3
-17%
|
6
+148%
|
12
+97%
|
0
N/A
|
16
N/A
|
12
-26%
|
20
+68%
|
12
-41%
|
24
+106%
|
14
-41%
|
13
-8%
|
11
-12%
|
7
-41%
|
7
+6%
|
|
| Shares Outstanding | ||||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
5
|
8
|
14
|
|
Switch to:
Switch to:
See Also
Discover More
